Alphatec Holdings Inc. (ATEC)
NASDAQ: ATECHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ATEC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.02B
- Forward P/E
- 11.97
- EPS (TTM)
- -$0.57
- Dividend yield
- None
- 52-week range
- 6.63 – 23.29
- Day range
- 6.63 – 7.00
- Volume / Avg
- 3.05M / 3.38M
- Beta
- —
- Shares outstanding
- 153.33M
52-week range
ATEC stock today
On Nov 20, ATEC ended the session at $6.68, shedding $0.22 (3.19%), versus the S&P 500's 3.70% decline. Shares are 71.3% below their 52-week high of $23.29, set on Jan 8, 2026 and 0.8% above the 52-week low of $6.63, near the bottom of the past year's range. ATEC is down 68.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 67.1%.
Alphatec has posted a net loss over the last twelve months (EPS of -$0.57), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Alphatec
Company profileAlphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Patrick S. Miles
- Headquarters
- Carlsbad, CA
- Employees
- 913
- IPO year
- 2006
- Website
- atecspine.com
Financial highlights
Full financialsIn fiscal 2025, Alphatec generated $764.2 million in revenue, up 25.0% from fiscal 2024, its 7th consecutive year of revenue growth. Alphatec reported a net loss of $143.4 million, compared with a loss of $162.1 million a year earlier. Gross margin was 69.6% (up from 69.4%) and operating margin -10.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $764.15M | $611.56M | $482.26M | $350.87M | $243.21M |
| Growth | +24.95% | +26.81% | +37.45% | +44.26% | +67.89% |
| Net income | $-143.36M | $-162.12M | $-186.64M | $-151.29M | $-143.03M |
| EPS (diluted) | $-0.96 | $-1.13 | $-1.54 | $-1.46 | $-1.49 |
Analyst forecast
ForecastConsensus (14 analysts)
strong_buy
Avg. price target
$12.93+93.56%
- Strong buy 3
- Buy 9
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 29, 2026
- EPS actual vs est.
- $-0.03 vs $-0.07
- Surprise
- +57.14%
ATEC news
All ATEC news- Alphatec Holdings (ATEC) Securities Investigation Notice - Levi & KorsinskyPR Newswire
- Monday 11/2 Insider Buying Report: ATEC, RBBNNasdaqATEC, RBBN
- ATEC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Alphatec HoldingsPR Newswire
- Alphatec Holdings Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Alphatec Holdings (ATEC)PR Newswire
- Alphatec (ATEC) Q3 2026 Earnings Call TranscriptNasdaqATEC, MKC.V
- Why is Alphatec Holdings stock plunging today?Investing.com
- Alphatec Holdings, Inc. Reports Third Quarter 2026 Total Revenue of $221 millionNasdaq
- Alphatec lowers FY 2026 revenue outlook to $862M while targeting 16% adjusted EBITDA marginSeeking Alpha
Alphatec peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SGPSpyGlass Pharma Inc. | 30.43 | -1.14% | $1.02B | vs ATEC |
| IARTIntegra LifeSciences Holdings Corporation | 13.25 | -2.21% | $1.03B | vs ATEC |
| IRMDiRadimed Corporation | 81.02 | -0.30% | $1.04B | vs ATEC |
| SIBNSI-BONE Inc. | 23.73 | -0.08% | $1.07B | vs ATEC |
| DRTSAlpha Tau Medical Ltd. | 11.76 | +3.93% | $1.09B | vs ATEC |
| AORTArtivion Inc. | 18.16 | -2.00% | $886.02M | vs ATEC |
| TNDMTandem Diabetes Care Inc. | 17.46 | +3.93% | $1.22B | vs ATEC |
| KIDSOrthoPediatrics Corp. | 31.74 | -2.37% | $828.75M | vs ATEC |
Indexes, lists and sector
Alphatec stock FAQ
What is Alphatec's stock price today?
ATEC last traded at $6.68 as of Nov 20, 4:00 PM EST, down 3.19% on the day. Prices are delayed at least 15 minutes.
Does Alphatec pay a dividend?
No. Alphatec does not currently pay a regular cash dividend.
Who is Alphatec's CEO?
Mr. Patrick S. Miles is the chief executive officer of Alphatec Holdings Inc., which has about 913 employees.
Has ATEC ever split its stock?
Yes. The most recent ATEC stock split was a 1-for-12 split on Aug 25, 2016.
What is the ATEC 52-week high?
The 52-week high for ATEC is $23.29 and the 52-week low is $6.63. The stock is currently 71.3% below its high.